Background: Photodynamic therapy (PDT) of superficial basal cell carcinomas using endogenous protoporphyrin IX generated by topically applied 5-aminolevulinic acid (5-ALA) is an innovative and clinically encouraging approach. Objective: This paper reports on the first results of an ongoing clinical study on photodynamic therapy of 55 basal cell carcinomas in 19 patients. Methods: Because of the chemical instability of 5-ALA, a novel nanocolloid lotion was developed. This formulation was applied to the lesions under occlusive dressing 6 h before irradiation with visible light from an unfiltered halogen lamp. Light-induced fluorescence was used to ascertain the superficial extension of the tumors. The response to the therapy was assessed by visual inspection and in 13 patients also by biopsies. Results: After a single treatment, 47 (85%) basal cell carcinomas showed a complete response at a follow-up time of at least 6 months. For the remaining 8 (15%) lesions, a partial response was observed, indicated by a marked reduction of the tumor size. The treatment modality without local anesthetics was well tolerated by all patients, with only slight discomfort during light irradiation. Conclusion: Our results indicate that 5-ALA-PDT with our novel formulation, a nanocolloid lotion, is a highly effective and convenient therapy for the treatment of superficial basal cell carcionomas. Its use in the treatment of nodular tumors needs further investigations.

Keywords:
Photodynamic Therapy, 5-Aminolevulinic acid, Basal cell carcinoma
1.
Dougherty TJ: Photoradiation therapy for cutaneous and subcutaneous malignancies. J Invest Dermatol 1981;77:122–124.
2.
Pass HI: Photodynamic therapy in oncology: Mechanisms and clinical use. J Natl Cancer Inst 1993;85:443–456.
3.
Kennedy JC, Pottier RH, Pross DC: Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J Photochem Photobiol B 1990;6: 143–148.
4.
Kennedy JC, Pottier RH: Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol 1992;14:275–292.
5.
Svanberg K, Andersson T, Killander D, Wang I, Stenram U, Andersson-Engels S, Berg R, Johansson J, Svanberg S: Photodynamic therapy of non-melanoma malignant tumors of the skin using topical d-amino levulinic acid sensitization and laser irradiation. Br J Dermatol 1994;130:743–751.
6.
Szeimies R-M, Sassy T, Landthaler M: Penetration potency of topical applied d-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem Photobiol 1994;59: 73–76.
7.
Szeimies R-M, Calzavara-Pinton P, Karrer S, Ortel B, Landthaler M: Topical photodynamic therapy in dermatology. J Photochem Photobiol B 1996;36:213–219.
8.
Manyak MJ, Russo A, Smith PD, Glatstein E: Photodynamic therapy. J Clin Oncol 1988;6: 380–391.
9.
Cairnduff F, Stringer MR, Hudson EJ, Ash DV, Brown SB: Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 1994;69:605–608.
10.
Karrer S, Szeimies RM, Hohenleutner U, Heine A, Landthaler M: Unilateral localized basaliomatosis: Treatment with topical photodynamic therapy after application of 5 aminolevulinic acid. Dermatology 1995;190: 218–222.
11.
Thiele B, Grotmann P, Hüttmann G, Diddens H, Hörauf H: Topische photodynamische Therapie von Basaliomen: Klinische, histologische und experimentalle Ergebnisse (erste Mitteilung). Z Hautkr 1994;69:161–164.
12.
Wolf P, Rieger E, Kerl H: Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J Am Acad Dermatol 1993;28:17–21.
13.
Fijan S, Hönigsmann H, Ortel B: Photodynamic therapy of epithelial skin tumors using d-aminolaevulinic acid and desferrioxamine. Br J Dermatol 1995;133:282–288.
14.
Calzavara-Pinton PG: Repetitive photodynamic therapy with topical d-aminolevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumors. J Photochem Photobiol B 1995;29: 53–57.
15.
Wennberg AM, Lindholm LE, Aplsten M, Larko O: Treatment of superficial basal cell carcinomas using topically applied delta-aminolevulinic acid and a filtered xenon lamp. Arch Dermatol Res 1996;288:561–564.
16.
Warloe T, Peng Q, Moan J, Qvist HL, Giercksky K-E: Photochemotherapy of multiple basal cell carcinoma with endogenous porphyrins induced by topical application of 5-aminolevulinic acid; in Spinelli P, Da Fante M, Marchesini R (eds): Photodynamic Therapy and Biomedical Lasers. Amsterdam, Elsevier Science, 1992, pp 449–453.
17.
König K, Schneckenburger H, Rück A, Steiner R: In vivo photoproduct formation during PDT with ALA-induced endogenous porphyrins. J Photochem Photobiol B 1993;18:287–290.
18.
Charlesworth P, Truscott TG: The use of 5-aminolaevulinic acid (ALA) in photodynamic therapy (PDT). J Photochem Photobiol B 1993;18:99–100.
19.
Szeimies R-M, Hein R, Bäumler W, Heine A, Landthaler M: A possible new incoherent lamp for photodynamic treatment of superficial skin lesions. Acta Derm Venereol (Stockh) 1994; 74:117–119.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.